People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Direct Flow Medical, Inc. | — | Other Health Care | Series C | $170.5M | $619.6M | 2009 |
| Vitara Biomedical, Inc. | — | Biotechnology | Series B | $70.0M | $63.2M | 2022 |
| CairnSurgical, Inc. | — | Other Health Care | Seed | $3.3M | $81.5M | 2019 |
Bernard Lyons at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bernard Lyons on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL LAVIOLETTE | 1 | 12 |
| Michael DeVries | 1 | 8 |
| Jeani Delagardelle | 1 | 8 |
| John Kelly | 1 | 7 |
| J. Daniel Cole | 1 | 7 |
| Manish Kothari | 1 | 6 |
| Ian Ratcliffe | 1 | 6 |
| Lee Wrubel | 1 | 5 |
| Mark Weeks | 1 | 4 |
| Scott Moonly | 1 | 3 |
| Aaron Kaplan | 1 | 3 |
| Jay Shukert | 1 | 2 |
| Jake Reder | 1 | 2 |
| Thomas Todorow | 1 | 2 |
| Ted Fjallman | 1 | 2 |
| Richard Barth | 1 | 2 |
| Michael E. DeVries | 1 | 1 |
| J. Daniel E. Cole | 1 | 1 |
| Gordon E. Bishop | 1 | 1 |
| Mike E. Burgess | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.